1. Endo thinks it has the financial flexibility to weather the storm of opioid settlements — Takeda acquires celiac-focused PvP Biologics — Iovance jumps on buyout rumors — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

ECR Pharmaceuticals

Anonymous board for ECR Pharmaceuticals


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    3
    Views:
    1,649
  2. anonymous
    Replies:
    9
    Views:
    2,586
  3. anonymous
    Replies:
    1
    Views:
    1,035
  4. anonymous
    Replies:
    0
    Views:
    848
  5. anonymous
    Replies:
    2
    Views:
    1,647
  6. anonymous
    Replies:
    0
    Views:
    1,576
  7. anonymous
    Replies:
    0
    Views:
    1,262
  8. anonymous
    Replies:
    1
    Views:
    1,749
  9. anonymous
    Replies:
    0
    Views:
    1,610
  10. anonymous
    Replies:
    0
    Views:
    1,503
  11. Anonymous
    Replies:
    1
    Views:
    2,247
  12. Anonymous
    Replies:
    2
    Views:
    2,311
  13. Anonymous
    Replies:
    6
    Views:
    3,592
  14. Anonymous
    Replies:
    1
    Views:
    3,398
  15. Anonymous
    Replies:
    2
    Views:
    2,881
  16. Anonymous
    Replies:
    10
    Views:
    4,682
  17. Anonymous
    Replies:
    7
    Views:
    5,013
  18. Anonymous
    Replies:
    99
    Views:
    23,165
  19. Anonymous
    Replies:
    13
    Views:
    5,054
  20. Anonymous
    Replies:
    7
    Views:
    4,671

Thread Display Options

Loading...